Validation and Standardisation of a "Neuralix" Digital Ecological Battery
NCT ID: NCT06830291
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
800 participants
OBSERVATIONAL
2025-03-11
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The VANOLIX study proposes the validation of the Neuralix cognitive battery with head trauma patients of moderate to severe intensity as well as its standardization with healthy volunteers, these two steps being essential to making the tool available to clinician-researchers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-defining Memories in Patients With a TBI
NCT02680210
Lariboisière Cognitive Assessment: Evaluation of the 1-year Outcomes
NCT06171568
Post-stroke Cognitive Impairment and Dementia
NCT01339195
Digital Cognition Study During Long-COVID
NCT06391970
"Cognitive Rehabilitation With Direct Current Transcranial Stimulation in Post-Traumatic Brain Injury Patients"
NCT06228872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
G1 : Control group: single assessment
healthy volunteers undergo the test battery only once
No interventions assigned to this group
G2 :Control group: double assessment
healthy volunteers undergo the test battery twice, six months apart
No interventions assigned to this group
G3 :Patient group: single assessment
patients undergo the test battery only once
No interventions assigned to this group
G4 : Patient group: double assessment
patients undergo the test battery twice, six months apart
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed consent to participate
* History of head trauma of moderate to severe intensity, i.e. having presented the high risk criteria of the study by Masters et al. (1987) at the time of the head trauma, and occurred a maximum of 5 years after inclusion in the VANOLIX study
Exclusion Criteria
* Subject with insufficient knowledge of counting (up to 25), the alphabet, reading, or French writing
* Subject with a severe intellectual disability
* Subject with past psychiatric or behavioral disorders requiring a stay \>2 days in a specialized environment or requiring current treatment other than a single anxiolytic
* Current treatment with antidepressant
* Current treatment with antipsychotic or multiple anxiolytics
* Single anxiolytic treatment initiated or increased for less than 1 month or current antiepileptic treatment
* Subject with a neurological condition or a history leading to cerebral dysfunction likely to interfere with the cognitive assessment
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital d'Instruction des Armées - Percy
Clamart, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01562-43
Identifier Type: OTHER
Identifier Source: secondary_id
2019PPRC08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.